These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 19528499)

  • 1. IL-6 and PPARgamma signalling in human PC-3 prostate cancer cells.
    Pitulis N; Papageorgiou E; Tenta R; Lembessis P; Koutsilieris M
    Anticancer Res; 2009 Jun; 29(6):2331-7. PubMed ID: 19528499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of IL-10-induced STAT3 activation by 15-deoxy-Delta12,14-prostaglandin J2.
    Ji JD; Kim HJ; Rho YH; Choi SJ; Lee YH; Cheon HJ; Sohn J; Song GG
    Rheumatology (Oxford); 2005 Aug; 44(8):983-8. PubMed ID: 15840591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-6 and oncostatin M stimulation of proliferation of prostate cancer 22Rv1 cells through the signaling pathways of p38 mitogen-activated protein kinase and phosphatidylinositol 3-kinase.
    Godoy-Tundidor S; Cavarretta IT; Fuchs D; Fiechtl M; Steiner H; Friedbichler K; Bartsch G; Hobisch A; Culig Z
    Prostate; 2005 Jul; 64(2):209-16. PubMed ID: 15712220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pigment epithelium-derived factor induces interleukin-10 expression in human macrophages by induction of PPAR gamma.
    Yang SL; Chen SL; Wu JY; Ho TC; Tsao YP
    Life Sci; 2010 Jul; 87(1-2):26-35. PubMed ID: 20553736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-6 stimulation of growth of prostate cancer in vitro and in vivo through activation of the androgen receptor.
    Malinowska K; Neuwirt H; Cavarretta IT; Bektic J; Steiner H; Dietrich H; Moser PL; Fuchs D; Hobisch A; Culig Z
    Endocr Relat Cancer; 2009 Mar; 16(1):155-69. PubMed ID: 19011039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EGR1 expression: a calcium and ERK1/2 mediated PPARγ-independent event involved in the antiproliferative effect of 15-deoxy-Δ12,14-prostaglandin J2 and thiazolidinediones in breast cancer cells.
    Chbicheb S; Yao X; Rodeau JL; Salamone S; Boisbrun M; Thiel G; Spohn D; Grillier-Vuissoz I; Chapleur Y; Flament S; Mazerbourg S
    Biochem Pharmacol; 2011 May; 81(9):1087-97. PubMed ID: 21338579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of growth of prostate cancer cells selected in the presence of interleukin-6 by the anti-interleukin-6 antibody CNTO 328.
    Steiner H; Cavarretta IT; Moser PL; Berger AP; Bektic J; Dietrich H; Zaki MH; Nakada M; Hobisch A; Nemeth JA; Culig Z
    Prostate; 2006 Dec; 66(16):1744-52. PubMed ID: 16998813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remnant lipoproteins stimulate proliferation and activate MAPK and Akt signaling pathways via G protein-coupled receptor in PC-3 prostate cancer cells.
    Sekine Y; Koike H; Nakano T; Nakajima K; Suzuki K
    Clin Chim Acta; 2007 Aug; 383(1-2):78-84. PubMed ID: 17512923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisome proliferator-activated receptor-gamma ligand reduced tumor necrosis factor-alpha-induced interleukin-8 production and growth in endometriotic stromal cells.
    Ohama Y; Harada T; Iwabe T; Taniguchi F; Takenaka Y; Terakawa N
    Fertil Steril; 2008 Feb; 89(2):311-7. PubMed ID: 17555752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C/EBPdelta is a downstream mediator of IL-6 induced growth inhibition of prostate cancer cells.
    Sanford DC; DeWille JW
    Prostate; 2005 May; 63(2):143-54. PubMed ID: 15486993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpressing PKIB in prostate cancer promotes its aggressiveness by linking between PKA and Akt pathways.
    Chung S; Furihata M; Tamura K; Uemura M; Daigo Y; Nasu Y; Miki T; Shuin T; Fujioka T; Nakamura Y; Nakagawa H
    Oncogene; 2009 Aug; 28(32):2849-59. PubMed ID: 19483721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dexamethasone suppresses DU145 cell proliferation and cell cycle through inhibition of the extracellular signal-regulated kinase 1/2 pathway and cyclin D1 expression.
    Gao QZ; Lu JJ; Liu ZD; Zhang H; Wang SM; Xu H
    Asian J Androl; 2008 Jul; 10(4):635-41. PubMed ID: 18097517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 15-deoxy-delta12,14 prostaglandin J2 synergizes with phorbol ester to induce proliferation in Swiss 3T3 cells independently of peroxisome proliferator-activated receptor gamma and PGD2 receptors.
    Castaño E; Gil J
    J Cell Physiol; 2003 Jun; 195(3):421-7. PubMed ID: 12704651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the AKT and STAT3 pathways and prolonged survival by a mutant EGFR in human lung cancer cells.
    Akca H; Tani M; Hishida T; Matsumoto S; Yokota J
    Lung Cancer; 2006 Oct; 54(1):25-33. PubMed ID: 16872715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiapoptotic activity of autocrine interleukin-22 and therapeutic effects of interleukin-22-small interfering RNA on human lung cancer xenografts.
    Zhang W; Chen Y; Wei H; Zheng C; Sun R; Zhang J; Tian Z
    Clin Cancer Res; 2008 Oct; 14(20):6432-9. PubMed ID: 18927282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of MKP3 mediated by oxidative stress enhances tumorigenicity and chemoresistance of ovarian cancer cells.
    Chan DW; Liu VW; Tsao GS; Yao KM; Furukawa T; Chan KK; Ngan HY
    Carcinogenesis; 2008 Sep; 29(9):1742-50. PubMed ID: 18632752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Galiellalactone is a novel therapeutic candidate against hormone-refractory prostate cancer expressing activated Stat3.
    Hellsten R; Johansson M; Dahlman A; Dizeyi N; Sterner O; Bjartell A
    Prostate; 2008 Feb; 68(3):269-80. PubMed ID: 18163422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytoprotective effect of tauroursodeoxycholate on hepatocyte apoptosis induced by peroxisome proliferator-activated receptor gamma ligand.
    Nonaka M; Tazuma S; Hyogo H; Kanno K; Chayama K
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e198-206. PubMed ID: 17868335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-6 protects LNCaP cells from apoptosis induced by androgen deprivation through the Stat3 pathway.
    Lee SO; Lou W; Johnson CS; Trump DL; Gao AC
    Prostate; 2004 Aug; 60(3):178-86. PubMed ID: 15176047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of MAPK signal transduction pathway phosphorylation induced by granulocyte-macrophage-colony stimulating factor in the proliferation of hormone-independent prostate cancer].
    Chen ZH; Wang HF; Ju W; Li H; Xiao YJ; Zeng FQ; Xiao CG
    Zhonghua Nan Ke Xue; 2006 Oct; 12(10):872-5. PubMed ID: 17121012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.